Clinical Trials Directory

Trials / Conditions / AIDS-related Kaposi Sarcoma

AIDS-related Kaposi Sarcoma

13 registered clinical trials studyying AIDS-related Kaposi Sarcoma — 1 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingPaclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma
NCT05411237
AIDS Malignancy ConsortiumPhase 3
CompletedDoxil/Caelyx BE Study
NCT05567601
Baxter Healthcare CorporationPhase 1
CompletedUse of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
NCT05510908
AIDS Malignancy Consortium—
TerminatedNT-I7 for Kaposi Sarcoma in Patients With or Without HIV
NCT04893018
Fred Hutchinson Cancer CenterPhase 1
UnknownEvaluation of Advanced HIV Disease Differentiated Care Model in Malawi
NCT05510973
Elizabeth Glaser Pediatric AIDS FoundationN/A
CompletedEvaluating Quality of Life in Patients With AIDS-Associated Kaposi Sarcoma Treated With Bleomycin and Vincrist
NCT03596918
AIDS Malignancy Consortium—
WithdrawnGamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma
NCT02137564
AIDS Malignancy ConsortiumPhase 2
CompletedLenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma
NCT01057121
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedBortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
NCT01016730
National Cancer Institute (NCI)Phase 1
WithdrawnSunitinib Malate in Treating East African Patients With Kaposi Sarcoma
NCT00521092
National Cancer Institute (NCI)Phase 2
CompletedHalofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's Sarcoma
NCT00064142
National Cancer Institute (NCI)Phase 2
TerminatedA Phase II Trial of COL-3 in Patients With HIV Related Kaposi's Sarcoma
NCT00020683
National Cancer Institute (NCI)Phase 2
CompletedPaclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's Sarcoma
NCT00003350
National Cancer Institute (NCI)Phase 3